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We previously identified the major structural determi-
nants of CCR5 binding and HIV blockade in RANTES,
describing linear RANTES-derived peptides with biologi-
cal activity in the low micromolar range (Nardese et al.,
2001). To deepen our understanding of RANTES struc-
ture-function relations and obtain more potent antiviral
peptido-mimetics, we have extensively mutagenized the
prototypic peptide, R11-29. This presents two clusters of
hydrophobic residues at its termini, (corresponding to
RANTES N-loop and b1-strand) connected by a positively-
charged linker. Single or multiple alanine substitutions
within the N- or C-terminal hydrophobic clusters resulted
in a dramatic loss of antiviral activity, whereas deletion of
selected residues within the hydrophilic linker had no
major functional consequences. Based on RANTES 3D
structure, we designed a series of modified peptides,
resulting in a progressive increase in specific antiviral
activity. These peptides also displayed anti-inflammatory
properties blocking RANTES-elicited lymphocyte chemo-
taxis. Through serial passages in culture in the presence of
increasing concentrations of the most effective antiviral
peptides, we have derived variants of the R5 HIV-1 isolate
BaL resistant to the peptide inhibitory activity. Complete
sequencing of the envelope genes from such variants is
currently underway. Our results provide new insights into
the structure of the receptor-binding region of RANTES
and identify new antiviral peptides that may be instru-
mental in the development of effective HIV-1 entry inhib-
itors.
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